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Free fatty acids hold dual roles during infection, serving to modulate the host immune
response while also functioning directly as antimicrobials. Of particular importance are
the long chain polyunsaturated fatty acids, which are not commonly found in bacterial
organisms, that have been proposed to have antibacterial roles. Arachidonic acid (AA) is
a highly abundant long chain polyunsaturated fatty acid and we examined its effect upon
Streptococcus pneumoniae. Here, we observed that in a murine model of S. pneumoniae
infection the concentration of AA significantly increases in the blood. The impact of
AA stress upon the pathogen was then assessed by a combination of biochemical,
biophysical and microbiological assays. In vitro bacterial growth and intra-macrophage
survival assays revealed that AA has detrimental effects on pneumococcal fitness.
Subsequent analyses demonstrated that AA exerts antimicrobial activity via insertion
into the pneumococcal membrane, although this did not increase the susceptibility of
the bacterium to antibiotic, oxidative or metal ion stress. Transcriptomic profiling showed
that AA treatment also resulted in a dramatic down-regulation of the genes involved in
fatty acid biosynthesis, in addition to impacts on other metabolic processes, such as
carbon-source utilization. Hence, these data reveal that AA has two distinct mechanisms
of perturbing the pneumococcal membrane composition. Collectively, this work provides
a molecular basis for the antimicrobial contribution of AA to combat pneumococcal
infections.
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INTRODUCTION
Host-derived free fatty acids play key roles in the defense against pathogenic bacteria, viruses
and fungi (Kohn et al., 1980; Zheng et al., 2005; Ells et al., 2009; Desbois and Smith, 2010).
Although primarily associated with compromising membrane integrity, studies from a range of
different bacterial species have shown that free fatty acids affect other cellular processes, including
energy production, nutrient uptake and enzyme activity, in niche-specific and organism-dependent
manners (Desbois and Smith, 2010). Free fatty acids have also been shown to impair colonization by
pathogenic microbes at the host-pathogen interface (Barakat et al., 2015; Mil-Homens et al., 2016).
The broad-spectrum and potential antimicrobial activity of fatty acids has attracted significant
interest as possible therapeutic agents (Jackman et al., 2016; Mil-Homens et al., 2016). However,
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determining the antimicrobial efficacy of free fatty acids is
complicated by the fact that many bacterial pathogens have
the ability to use host fatty acids as an energy source and/or
in the synthesis of their own membranes (Balemans et al.,
2010). A prominent example is Mycobacterium tuberculosis,
wherein persistence within macrophages is believed to be reliant
upon incorporation of host fatty acids into the bacterial cell
(Peyron et al., 2008; Caire-Brändli et al., 2014). Accordingly,
the advantage conferred by use of host fatty acids is likely
to be greatest when the host fatty acids are similar to
the bacterium’s own endogenous fatty acids. Consistent with
this inference, host-produced long chain-polyunsaturated fatty
acids (LC-PUFAs; ≥20 carbons and ≥2 double bonds) often
display greater antibacterial potential than medium/short chain
saturated and monounsaturated fatty acids (≥18 carbons and
0 or 1 double bonds), which are produced by both the host
and bacteria (Desbois and Smith, 2010). The omega-6 LC-
PUFA arachidonic acid (20:4n-6) is known as a precursor for
the immunomodulatory prostaglandins (Bhowmick et al., 2013,
2017), but it is also one of the most abundant broad spectrum
antimicrobial fatty acids, affecting bacteria, viruses and fungi
(Kohn et al., 1980; Zheng et al., 2005; Ells et al., 2009).
Streptococcus pneumoniae (the pneumococcus) remains the
world’s foremost bacterial pathogen, responsible for the deaths
of ∼1 million individuals annually. Many of its virulence
factors have been analyzed for their contribution to disease
and survival at the host-pathogen interface. Despite this, there
is a relative paucity of knowledge regarding the antimicrobial
contribution of fatty acids on the ability of the pneumococcus
to cause disease. Pneumococcal fatty acids required for the cell
membrane are synthesized by the type II fatty acid synthase
(FASII) system (Zhang and Rock, 2008), which is encoded from
a single gene cluster (SPD_0378-0390; fab-cluster). Regulation
of this cluster is mediated by the MarR-type regulator FabT
(SPD_0379), which represses transcription of the fab-cluster
upon binding of fatty acids (Jerga and Rock, 2009). In addition
to de novo synthesis by the FASII system, the pneumococcus
has the ability to incorporate exogenous fatty acids into its
membrane through the FakA/B system (Parsons et al., 2015). The
components of both the FASII system and FakA are essential for
in vivo survival (van Opijnen and Camilli, 2012). However, the
mechanism(s) through which antimicrobial fatty acids affect the
FASII and FakA/B systems, and other crucial cellular processes
remains largely unknown. Despite this, studies have shown an
association between exogenous fatty acids and restriction of
pneumococcal colonization. A recent study of Corynebacterium
accolens showed that the bacterial triacylglycerol (TAG) lipase
could cleave host TAGs generating antimicrobial free fatty
acids that impacted pneumococcal colonization (Bomar et al.,
2016). This corresponded with Corynebacterium spp. being
overrepresented in children that were not colonized with
S. pneumoniae. Further, alveolar macrophages isolated from
mice fed on a diet rich in LC-PUFAs exhibited enhanced
phagocytic clearance of pneumococci (Saini et al., 2013). These
studies highlight the ability of exogenous fatty acids to restrict
Abbreviations: AA, arachidonic acid; PBS, phosphate-buffered saline.
pneumococcal colonization, although the molecular basis for the
antimicrobial activity of free fatty acids remains unknown.
In this study, we examine the antimicrobial potential of
arachidonic acid (AA) against S. pneumoniae in in vitro and
cell culture assays. At a molecular level, our data reveal that
AA elicits antimicrobial activity against S. pneumoniae, altering
the pneumococcal membrane via two distinct mechanisms.
Our genome-wide analyses did not uncover any resistance
mechanisms to counteract AA toxicity, highlighting the
potential of antimicrobial fatty acids as a highly effective
anti-pneumococcal therapy.
MATERIALS AND METHODS
S. pneumoniae Strains and Growth
Conditions
Opaque phase variants of S. pneumoniae strain D39 or its fakB
(SPD_0646) deletion-replacement derivative were examined in
this study. The fakB mutant was generated by replacement
with an erythromycin resistance cassette, as described previously
(Plumptre et al., 2014a) using the oligonucleotides listed in
Table S1. Bacteria were routinely grown overnight at 37◦C with
5%CO2 on Columbia agar supplemented with 5% (vol/vol) horse
blood. For subsequent assays, bacteria were grown in a casein-
based semisynthetic medium (C+Y with 0.2% glucose) (Lacks
and Hotchkiss, 1960) or, for challenge of mice, in serum broth
(10% heat-inactivated horse serum [Thermo Fisher Scientific]
in nutrient broth [Oxoid]). For growth analyses, S. pneumoniae
D39 and the fakB mutant strain were grown in C+Y until
they reached an optical density at 600 nm (OD600) of 0.3. They
were then subcultured into 200 µl C+Y (with or without AA
[Sigma-Aldrich], H2O2, paraquat, gentamicin, chloramphenicol,
zinc and/or copper) to a final OD600 of 0.01. The bacteria were
incubated at 37◦C in a CO2-enriched atmosphere, with growth
monitored by measurement of the OD600 at 30min intervals on
a FLUOstar Omega (BMG Labtech).
Population Viability Assessment
Following growth tomid-log phase in C+Ymedium at 37◦Cwith
5% CO2, cells were washed three times to remove excess AA.
Cells were then shock-treated with 4 µg.mL−1 LL-37 for 30min
in PBS. The viability of washed cells was determined by staining
for 5min with Sytox Green (Molecular Probes). At least 8,000
cells were then assessed on a BD Accuri flow cytometer, with the
data analyzed using FlowJo 10.2 (BD). Dead cells (Sytox Green
positive) were gated using the FITC intensity of unlabeled cells.
AA treatment alone did not result in increased cell death of D39,
with only LL-37 inducing death. Data represent an average of at
least biological triplicates.
Murine Infection
Murine infection experiments were conducted as described
previously (Plumptre et al., 2014a,b; Eijkelkamp et al., 2016).
Outbred 5- to 6-week old female CD1 (Swiss) mice were
used in all animal experiments. Mice were anesthetized by
intraperitoneal injection of pentobarbital sodium (Nembutal;
Rhone-Merieux) at a dose of 66 µg.g of body weight−1, followed
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by intranasal administration of 50 µl bacterial suspension in
serum broth, containing approximately 1 × 107 colony forming
units (CFUs). The challenge dose was confirmed retrospectively
by serial dilution and plating on blood agar. At 24 h post-
challenge, mice were euthanized by CO2 asphyxiation. Blood
was collected by syringe from the posterior vena cava and
transferred to a heparinized tube. A small aliquot was serially
diluted and plated on blood agar for CFU counts. Plasma was
isolated from the remainder of the sample and submitted for
fatty acid analyses as described below. All procedures performed
in this study were conducted with a view to minimizing the
discomfort of the animals, and used the minimum numbers
to generate reproducible and statistically significant data. All
experiments were approved by the University of Adelaide Animal
Ethics Committee (Animal Welfare Assurance number A5491-
01; project approval number S-2013-053) and were performed in
strict adherence to guidelines dictated by the Australian Code of
Practice for the Care and Use of Animals for Scientific Purposes.
Fatty Acid Analyses
For analysis of the bacterial fatty acids, cultures were grown
to an OD600 of 0.3 in C+Y media at 37
◦C with 5% CO2,
cells were washed in phosphate buffered saline (PBS) and then
disrupted by sonication for 60 cycles (30 s on and 30 s off) on a
Bioruptor (Diagenode). The fatty acid content of the bacterial cell
lysates and murine plasma was then analyzed by GC-MS at the
Waite Analytical Services (University of Adelaide) as described
previously (Eijkelkamp et al., 2013; Pederick et al., 2014). The
statistical differences between samples (n ≥ 3) were examined
using an unpaired Student t-test (Graphpad Prism 6.0c).
Macrophage Killing Assays
Macrophage killing assays were performed as previously
described (Hassan et al., 2017; Martin et al., 2017). THP-1
cells (ATCC TIB-202) were grown under atmospheric control
(95% air and 5% CO2) at 37
◦C in complete RPMI medium
(RPMI with phenol red [Gibco], supplemented with 10% fetal
bovine serum, 10mM HEPES, 30 µg.mL−1 penicillin and 50
µg.mL−1 streptomycin). Cell culture flasks (25 cm2; BD Falcon)
were seeded with 3.5 × 106 THP-1 cells and differentiated by
adding 100 ng.mL−1 phorbol 12-myristate 13-acetate (PMA;
Sigma-Aldrich) and incubated for 3 days. Attached differentiated
THP-1 cells (macrophages) were washed in complete RPMI and
incubated with complete RPMI without added PMA for> 2 days
to allow resting. Two hours before challenge with S. pneumoniae,
a subset of macrophages was treated with 5µM AA (Sigma-
Aldrich), which represents a concentration appropriate for
treatment of cell cultures (Caruso et al., 1994; Ghioni et al.,
1997; Hughes-Fulford et al., 2005; Gregory et al., 2011). The
AA was pre-incubated with fatty acid free BSA (Sigma) at
a 4:1 ratio (AA:BSA) to allow for efficient delivery of AA
to THP-1 cells, following standard fatty acid supplementation
procedures (Ghioni et al., 1997). Following thorough washing (3
times in Hank’s Balanced Salt Solution [HBSS; Thermo Fisher
Scientific]), THP-1 cells were detached using 1mL StemPro
Accutase (Thermo Fisher Scientific) and washed again for 3
times to remove the residual StemPro Accutase. Following
viability assessment and enumeration by trypan blue staining and
microscopy, THP-1 cells were diluted to 1.1 × 105 cells.mL−1 in
HBSS.
S. pneumoniaeD39were grown overnight on blood agar plates
at 37◦C with 95% air and 5% CO2 and subsequently inoculated
into C+Y media (Begg et al., 2015) to an OD600 of 0.05. The
cultures were grown at 37◦C with 5% CO2 until the OD600
reached 0.3, after which the cells were washed, resuspended in
HBSS, and CFU counts determined by plating on blood agar.
The macrophages and S. pneumoniae cells were co-incubated at
a ratio of 1:10 for 90min. The macrophages were then washed
and extracellular bacteria were killed by incubation with 200
µg.mL−1 gentamicin and 10 µg.mL−1 penicillin for 30min.
The macrophages were washed in HBSS without antibiotic and
incubated for a further 60min prior to analysis of intracellular
bacteria by lysing the macrophages with 0.0625% Triton-X-100.
The lysates were then plated onto blood agar. The CFUs were
enumerated and corrected for input. The data are the mean of at
least four biological replicates (±SEM). The statistical differences
between pneumococcal survival in AA-treated and untreated
THP-1 cells were examined using an unpaired Student t-test.
qRT-PCR Analyses
For isolation of RNA, 500 µl of a S. pneumoniae culture at an
OD600 of 0.3, grown in C+Y media at 37
◦C with 5% CO2, was
mixed with 1ml of RNA Protect (Qiagen). RNA was extracted
and purified using an RNeasy Bacteria Mini Kit (Qiagen) after
enzymatic lysis using lysozyme and mutanolysin, as described
previously (Eijkelkamp et al., 2014a, 2015, 2016; Plumptre et al.,
2014a,b; Begg et al., 2015). The total RNA samples were treated
with DNase I (Roche) and qRT-PCR was carried out using a
SuperScript III One-Step RT-PCR kit (Thermo Fisher Scientific)
on a LC480 Real-Time Cycler (Roche). Transcription levels
of genes analyzed were normalized to those obtained for 16S
rRNA. Primer sequences are available in Table S1. Results are
representative of at least four independent samples and the
statistical difference was examined by an unpaired Student t-test
(Graphpad Prism 6.0c).
Transcriptomic Analyses
RNA isolated from biological quadruplicates of S. pneumoniae
D39 grown with or without 62.5µM AA in C+Y media at
37◦C with 5% CO2 was pooled and submitted to the Australian
Genomics Research Facility for sequencing. Briefly, the RiboZero
bacterial rRNA removal kit (Illumina) was used to reduce the
ribosomal RNA content of the total RNA pool, followed by use
of the TruSeq Stranded mRNA Library Prep Kit (Illumina) to
generate the barcoded libraries. Prepared libraries were then
sequenced using the Illumina HiSeq2500 with Version 3 SBS
reagents and 1× 100 bp single-end chemistry. Reads were aligned
to the S. pneumoniae D39 genome using BOWTIE2 version
2.2.3 (Langmead and Salzberg, 2012). Counts for each gene were
obtained with the aid of SAMtools (v 0.1.18) (Li et al., 2009)
and BEDtools (Quinlan and Hall, 2010) and differential gene
expression was examined using R DESeq (Anders and Huber,
2010; Pederick et al., 2015). In the text and in Figure 4 and
Table S2 we have highlighted the genes that were found to be
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statistically different as determined by DESeq. The complete data
set has been submitted to GEO (accession number GSE93102).
Membrane Fluidity
Bacterial cultures were grown to an OD600 of 0.3 in C+Y
media at 37◦C with 5% CO2 and cells were washed in
PBS. Bacteria were than incubated with 1,6-diphenyl-1,3,5-
hexatriene (DPH), which was dissolved in tetrahydrofuran.
After incubation at 37◦C for 30min, cells were washed and
fluorescence polarization (excitation 350/emission 450 nm) was
determined on a PHERAstar spectrophotometer (BMG Labtech).
The relative change inmembrane fluidity was determined from at
least 3 independent experiments and the statistical difference was
assessed by an unpaired Student t-test.
Whole Cell Metal Ion Accumulation
S. pneumoniae strains were grown to an OD600 of 0.3 in C+Y
media at 37◦C with 5% CO2 and the total cell-associated metal
ion content was determined essentially as described previously
(Eijkelkamp et al., 2014a, 2016; Pederick et al., 2015). Succinctly,
bacteria were washed three times with PBS + 5mM EDTA, then
washed four times with PBS. Bacterial pellets were desiccated by
heating at 95◦C overnight. The dry cell weight was measured
and the pellets resuspended in 35% HNO3. Metal ion content
was measured on an Agilent 7500cx inductively coupled plasma-
mass spectrometer (Adelaide Microscopy). The data represents 6
biological replicates and the statistical difference assessed by an
unpaired Student t-test (Graphpad Prism 6.0c).
Ethanol Detection Assays
Intracellular ethanol abundance was determined using
Megazyme Ethanol Detection kit as per manufacturer’s
instructions. Briefly S. pneumoniae D39 was grown in C+Y with
or without 62.5µM AA supplementation, to an OD600 of 0.3
at 37◦C with 5% CO2. One milliliter of culture was harvested
via centrifugation (12,000 × g for 5min) and resuspended in
200 µl of ethanol-free ddH2O. Bacterial cells were lysed by
incubation with 0.1% (v/v) deoxycholate for 10min at 37◦C,
and 100 µl of cell lysate was analyzed for ethanol abundance
via absorbance at 340 nm on a PHERAstar spectrophotometer
(BMG Labtech). The data represents > 4 biological replicates
and statistical analyses were performed by an unpaired Student
t-test (Graphpad Prism 6.0c).
YtrA and FabT Binding Site Identification
The YtrA and FabTmotifs were generated as described previously
(Eijkelkamp et al., 2011a,b, 2014b; Giles et al., 2015). For YtrA, the
independent binding sites that served as a template were obtained
from Suvorova et al. (2015), and for FabT from Marrakchi et al.
(2002). In brief, the binding site sequences were aligned using
Clustal Omega (Sievers et al., 2011) to generate the binding
site motif. The putative binding sites were then identified using
HMMER 2.0 (Finn et al., 2011) as an integral part of UGENE
(Okonechnikov et al., 2012).
RESULTS AND DISCUSSION
Abundance of Arachidonic Acid and its Antimicrobial
Activity
To study the role of free fatty acids in restricting pneumococcal
proliferation during infection, we first determined the
concentrations of plasma fatty acids and their potential fluxes
upon infection. Outbred female Swiss mice were intranasally
challenged with the virulent S. pneumoniae type 2 strain D39 or
with PBS as a control. At 24 h post-challenge, the pneumococci
caused a systemic infection with an average bacterial count of
1.5 × 107 CFU.mL−1 (SD ± 2.3 × 106) in the blood. Plasma
fatty acid content of infected, and naïve control mice, were
quantitatively determined after methanol-chloroform extraction
by gas-chromatography (GC) (Eijkelkamp et al., 2013; Pederick
et al., 2014). The acyl chains of the major fatty acids (>1%
relative abundance) identified in the plasma were between
16 and 22 carbons in length (Figure 1A). These included
two saturated fatty acids, palmitic acid (16:0) and stearic acid
(18:0), two omega-6 fatty acids, linoleic acid (18:2n-6) and
arachidonic acid (20:4n-6), the omega-9 fatty acid oleic acid
(18:1n-9) and the omega-3 fatty acid docosahexaeonic acid
(22:6n-3). Significant changes in AA were observed upon the
establishment of infection, from 1.1 to 1.6mM (44% increase;
p< 0.05), in our pneumonia-bacteremiamodel of pneumococcal
infection. This specific modulation of AA abundance in plasma
suggests that it may play an important role in host defense
against pneumococcal infection. AA is primarily known for
its pro-inflammatory activity, serving as a major precursor
for classic eicosanoids, such as prostaglandins, although this
fatty acid has also been associated with antimicrobial activity
against a range of pathogenic organisms (Kohn et al., 1980;
Das, 1985; Ells et al., 2009; Desbois and Smith, 2010; Jackman
et al., 2016; Mil-Homens et al., 2016). Here we focused on the
direct antimicrobial properties of this LC-PUFA and sought
to examine this in vitro. We observed that S. pneumoniae
D39 is highly susceptible to AA, with growth significantly
perturbed upon supplementation with 62.5µM AA into
the culture medium. Growth of the pathogen was almost
completely abrogated by supplementation with 125µM AA
(Figure 1B). Notably, the concentrations examined here are far
below those observed in murine plasma (1.6mM; Figure 1A),
suggesting a physiological relevance of potent AA toxicity during
infection.
Fatty acids play important roles in phagocytic cells, where
omega-6 fatty acids, such as AA, are associated with enhanced
phagocytic functionality by mechanisms such as improved
phagolysosome maturation and greater bacterial killing (Anes
et al., 2003; Jordao et al., 2008). Further, the release of AA
from membrane phospholipids is critical for the production
of the neutrophil chemoattractant, hepoxillin A3, which has
key roles in systemic pneumococcal infections (Bhowmick
et al., 2017). Fatty acids have also been proposed to target
phagocytosed pathogens within macrophages through fusion
of the phagolysosome with lipid bodies containing high
concentrations of fatty acids (Adolph et al., 2012; Caire-
Brändli et al., 2014). Given the observed susceptibility of
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FIGURE 1 | Examination of arachidonic acid as an anti-pneumococcal agent. (A) Examination of plasma fatty acids before and after infection with S. pneumoniae
strain D39. (B) Examination of pneumococcal growth upon treatment with AA at 62.5, 125, or 250µM. The OD600 was determined every 30min. (C) Intracellular
survival of pneumococci within THP-1 derived macrophages treated with 5µM AA by comparison with untreated macrophages. All data are the mean of at least
biological triplicates (±SEM) and where error bars are not visible this is due to occlusion by the shown symbols. Statistical analyses were performed using a Student’s
t-test (*p<0.05).
S. pneumoniae to AA and the significant role of AA in immune
modulation, we hypothesized that AA may play a crucial
role in controlling pneumococci within macrophages. Here,
we ascertained the effect of AA on human THP-1 derived
macrophages, by examining loading of S. pneumoniae within
AA-treated macrophages compared to untreated macrophages.
We observed nearly a 50% reduction in pneumococcal loading
by AA-treated macrophages by comparison with untreated
macrophages (Figure 1C), highlighting the importance of
AA in phagocytic cells. The reduction in pneumococcal
loading in AA-treated macrophages may arise from AA
improving lysosomal maturation or by AA interfering with the
internalization of pneumococci. Alternatively, AA may have
a direct antimicrobial role within macrophages and enhance
killing of the phagocytosed bacteria. Irrespective of the precise
mechanism, our analyses of serum AA levels during infection,
the effect of AA on macrophages and the direct impact of
AA on pneumococcal fitness, shows the significance of AA in
combatting pneumococcal infections.
Arachidonic Acid Targets the Pneumococcal
Membrane
One route by which AA exerts an impact on bacterial organisms
is via membrane incorporation. Here, we sought to investigate
whether this occurred in S. pneumoniae by examining cells grown
in the presence of 62.5µM AA and assessing membrane fluidity
by fluorescence polarization using 1,6-diphenyl-1,3,5-hexatriene
(DPH). These assays showed that pneumococcal membranes
were significantly impacted by this relatively mild treatment (15-
min growth delay at mid-log phase), with membrane fluidity
increased by 31% (p < 0.0001) compared to untreated cells
(Figure 2A).
Membrane fluidity is predominantly determined by the
acyl groups of the fatty acids. To examine the effects of AA
treatment on the pneumococcal cell membrane composition, we
quantitatively determined the fatty acid content of untreated
and 62.5µM AA treated cells (Figure 2B). In untreated cells,
we identified 4 saturated fatty acids, 12:0 (5.4%), 14:0 (11.1%),
16:0 (41.6%), and 18:0 (6.4%), as well as 3 monounsaturated
fatty acids; 16:1n-7 (14.0%), 18:1n-7 (15.7%), and 18:1n-9 (3.3%).
Upon treatment, we observed that AA was readily incorporated
into the cell, resulting in AA abundance accounting for 31.5%
of the cellular fatty acids (Figure 2B). Taken together, these
data provide a plausible basis for the observed increase in the
membrane fluidity in AA-treated cells.
Intriguingly, the impact of AA treatment upon the
endogenous fatty acid content of the pneumococcal membrane
was greatest for the 2 monounsaturated omega-7 fatty acids,
16:1n-7 and 18:1n-7, which decreased by more than 2- and 3-
fold, respectively (Figure 2B). Although relatively less dramatic,
the abundance of 16:0 decreased by approximately 10%. Minor
decreases were observed in the abundance of 12:0 and 14:0,
whereas 18:0 showed a small increase.
To examine the effect of the changes in the membrane
composition and its fluidity on stress resistance, we examined
the survival of untreated and AA-treated cells to the human
antimicrobial peptide LL-37 (Figure 2C). First, the FSC-SSC
profiles of pneumococci were assessed and observed to not
be significantly affected by treatment with AA, LL-37 or the
combination of these antimicrobials. Interestingly, AA-treated
cells were highly resistant to LL-37, with a 72% survival in
untreated cells and 97% in AA-treated cells (p < 0.0001). This
may be a result of AA binding the membrane targeting peptide,
thereby diminishing its antimicrobial potential. Treatment
with AA did not significantly change pneumococcal growth
in the presence of the hydrophilic antibiotic gentamicin or
the hydrophobic antibiotic chloramphenicol (Figure S1A,B).
Although AA and gentamicin exert an additive antimicrobial
effect, treatment with AA and chloramphenicol elicited the
same effect as treatment with chloramphenicol only. Metal
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FIGURE 2 | The effects of arachidonic acid on the pneumococcal membrane. (A) The membrane fluidity was determined by examining the fluorescence polarization
of 1,6-diphenyl-1,3,5-hexatriene (DPH) in the cellular membrane. The relative membrane fluidity in AA-treated cells (62.5µM) was corrected to that observed in
untreated cells. (B) The major cellular fatty acid constituents of S. pneumoniae, grown in the presence of 62.5µM AA, or without AA supplementation were
determined by gas chromatography. The abundance of fatty acids is expressed as percentage of total cellular fatty acids. (C) The survival following shock-treatment
with 4 µg.mL−1 LL-37 for 30min was determined by staining with Sytox green (Molecular Probes) and subsequent flow cytometric cell counting (BD Accuri). For all
panels, the data are the mean of at least biological triplicates (± SEM). For the membrane fluidity (A) and fatty acid analyses (B), statistical analyses were performed
by Student’s t-test (ns, not significant; *p < 0.05; **p < 0.01, and ****p < 0.0001). For the cell viability assay (C), statistical analyses were performed using a one-way
ANOVA (ns, not significant; ****p < 0.0001).
ion intoxication by copper and zinc is known to exert potent
antimicrobial activity toward S. pneumoniae (Eijkelkamp et al.,
2014a; Johnson et al., 2015) and this has been shown to act
synergistically with AA in other bacteria (Hassan et al., 2017).
However, treatment of pneumococci with AA did not reveal
major changes in their ability to grow in the presence of zinc
or copper. Similar to our observations for chloramphenicol, AA
stress did not cause a greater growth perturbation than that
observed for the metal stress independently, thereby indicating
that altered membrane fluidity did not affect zinc or copper
homeostasis (Figure S1C,D).
Collectively, these analyses show that AA stress on
S. pneumoniae perturbs pneumococcal cell integrity by direct
incorporation into the bacterial cell membrane, resulting in
altered membrane composition and increased fluidity. Despite
this, perturbation of the cell membrane did not increase the
susceptibility of the pneumococcus to exogenous antibiotic or
metal ion stress. Further, AA treatment provided protection
against the membrane-targeting host antimicrobial peptide
LL-37.
Arachidonic Acid Stress and the Effect on the
Pneumococcal Transcriptome
To gain greater insight into the effect of AA on pneumococcal
physiology we examined the complete transcriptomic response
of the bacterium to exogenous AA treatment. Pneumococcal
cells were grown in the presence of 62.5µM AA until mid-log
phase, with the transcriptomic responses of the two groups (4
pooled biological replicates per condition) examined by RNA
sequencing. Overall, 110 genes (5.3%) were up-regulated and 103
genes (5.2%) down-regulated by more than a 2-fold (Figure 3
and Table S2). Further analysis of a subset of 5 genes displayed
a strong correlation between analysis by RNA sequencing and
qRT-PCR (R2 = 0.9847; Figure S2).
The fab fatty acid biosynthesis cluster was found to be
significantly affected by AA (Figure 4A,B). Here, we observed
significant down-regulation of the fab fatty acid biosynthesis
genes ranging from 3.7-fold (accA) to 4.8-fold (fabK). These
findings implicate FabT as being responsive to the increased
abundance of AA and mediating repression of the fab gene
cluster. Prior work has shown that deletion of fabT results
in increased expression of all genes in the fab cluster, except
for fabM (Lu and Rock, 2006; Jerga and Rock, 2009), despite
the presence of a putative FabT binding site upstream of
fabM (Marrakchi et al., 2002) (Figure 4). Here, we observed
that, similar to the other genes in the fab-cluster, fabM was
significantly down-regulated upon exposure to AA (7-fold). Jerga
and Rock (2009) showed that FabT had the greatest affinity
for the FabT-binding site of fabK when bound to the longest
unsaturated endogenous fatty acid analyzed in their study, 18:1.
By contrast, shorter chain and saturated fatty acids resulted in
lower affinity interactions of FabT with the fabK operator site
(Jerga and Rock, 2009). Hence, we propose that AA (20:4), a
LC-PUFA, binds to FabT resulting in a complex that has an
increased affinity for its DNA targets, including the putative
FabT-binding site upstream of fabM. However, we have no
direct evidence for this and so an alternative possibility is that
endogenous long chain fatty acids may also accumulate in the
cytosol leading to highly repressive FabT-complexes. Irrespective
of the precise mechanism, whether direct or indirect, the impact
on endogenous fatty acid biosynthesis is mediated in response to
increased AA abundance.
Despite the fact that fab gene clusters show a high level
of homology within the species, comparative genomic analyses
revealed significant strain-to-strain variation in the genomic
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FIGURE 3 | The transcriptomic responses of S. pneumoniae to AA treatment. RNA sequencing of untreated and AA-treated (62.5µM) S. pneumoniae D39 was used
to determine relative gene expression (expressed as log2-fold change compared to untreated). Each symbol represents a gene, with each gene distributed on the
X-axis in accordance with locus tag numbering for strain D39. Genes upregulated upon AA treatment are presented above the X-axis (blue circles > 2-fold and blue
diamonds > 4-fold), with those below the X-axis expressed at a lower level upon AA treatment (orange circles > 2-fold and orange diamonds > 4-fold). Genes of
interest are annotated with their putative or characterized functions.
region between the FabT-binding site and the start of the
fabM open reading frame (Figure 4B). This suggests that fabM
expression may differ between S. pneumoniae strains leading to
differences in the relative abundance of unsaturated fatty acids
and hence membrane fluidity, although further studies will be
required to determine veracity of this inference. Transcription
of fabT, which auto-regulates its expression, and fabH, which is
co-transcribed with fabT, showed minor down-regulation upon
AA treatment, a common observation for auto-regulated genes
(Eijkelkamp et al., 2011b; Plumptre et al., 2014a). By contrast,
transcription of acpP, which encodes the acyl-carrier protein
(ACP), was not affected by AA stress (Figure 4B), indicating that
it is the enzymatic conversions within the FASII pathway that are
rate limiting (Figure 4A).
Analysis of pneumococcal fatty acid composition revealed
that AA treatment induced the greatest changes on the omega-
7 monounsaturated fatty acids (Figure 2B). Down-regulation of
fabM under AA stress, which plays a key role in the formation
of unsaturated fatty acids in the pneumococcal membrane
(Lu and Rock, 2006; Figure 4A), could be the cause of the
observed depletion of 16:1n-7 and 18:1n-7 in S. pneumoniae.
In addition to the impacts on fatty acid biosynthesis via the
fab-gene cluster, other membrane homeostasis-related genes also
exhibited differential transcription in response to AA treatment.
Transcriptomic analyses revealed that bioY, which encodes
the biotin uptake protein, was down-regulated by 4.5-fold in
response to AA treatment. Biotin is essential for the biosynthesis
of fatty acids (Figure 4A) and this finding suggests that during
AA stress, the decreased production of endogenous fatty acids
may be due a concomitant reduction in biotin accumulation.
Disruption of membrane homeostasis is also implicated by the
down-regulation of SPD_0646 (3.7-fold), a DegV-like protein
suggested to be involved in the maintenance of the cell’s fatty acid
composition. In Staphylococcus aureus, the DegV-like proteins,
FakB1 and FakB2, have been shown to be involved in the
acquisition of extracellular fatty acids. These fatty acids can
subsequently be incorporated in the bacterium’s membrane via
PlsX (Parsons et al., 2014). Consequently, we investigated the
contribution of the putative FakB (SPD_0646) in pneumococcal
susceptibility to AA. We observed that the growth of a fakB
mutant upon treatment with AA was no different to the wild-
type (Figure S3). However, it is plausible that fakB is dysregulated
by AA, with fatty acids other than AA being substrates of the
encoded FakB protein. Hence, we examined the susceptibility
of the fakB mutant to the second most highly abundant LC-
PUFA in mouse serum, the omega-3 fatty acid, docosahexaenoic
acid (DHA) (Figure 1A). Interestingly, these analyses revealed a
minor, but discernable increase in perturbation by 62.5µMDHA
in the fakB mutant, by comparison to the wild-type (Figure S3).
Therefore, while it is possible that the down-regulation of
SPD_0646 is a mechanism to limit AA toxicity, the physiological
substrates of the pneumococcal FakB protein are likely to be a
range of different types of fatty acids, such as DHA.
SPD_1874, which encodes a putative peptidoglycan-binding
LysM-domain containing protein, was also significantly
downregulated (4.5-fold) upon AA treatment. The cluster
harboring this gene (SPD_1871-76) has previously been shown
to be regulated by YycFG, a global two-component regulator
(Ng et al., 2003). YycFG has also been shown to regulate fabT,
with overexpression of YycF resulting in an altered cellular
fatty acid composition (Mohedano et al., 2005, 2016). As a
consequence, we cannot exclude the possibility that fabM may
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FIGURE 4 | A schematic representation of the fatty acid biosynthesis cluster. (A) The fatty acid biosynthesis pathway of the pneumococcus consists of two major
parts; initiation (light blue) and elongation (light red). A red arrow indicates genes that are down-regulated upon AA treatment and in black those not affected by AA.
ACP is acyl carrier protein and CoA is Coenzyme A. (B) The RNAseq coverage of untreated cells (dark gray) and of AA-treated cells (light gray) are presented relative
to their genomic positioning. The open reading frames of the components of the fab-cluster are indicated, to scale, in the black arrows, and adjacent genes of
unrelated function in gray. The putative FabT binding sites are indicated by the black arrow heads, upstream of fabM, fabT, and fabK. The region of significant
strain-to-strain variation upstream of fabM is indicated in the box with diagonal stripes.
be co-regulated by other systems such as YycFG. Although,
not all previously identified regulatory targets of YycFG were
found to be differentially expressed upon AA treatment in our
study, the SPD_0771-73 gene cluster, which encodes a fructose
phosphotransferase system (PTS) repressor (SPD_0771),
phosphofructokinase (SPD_0772) and fructose PTS system
enzyme II ABC (SPD_0773), was significantly upregulated
(Table S2), corroborating previous studies of YycFG (Ng et al.,
2003). Transcription of the yycF and yycG genes increased by
1.3- and 1.2-fold upon AA stress, respectively.
The riboflavin biosynthesis pathway (SPD_0166-9) was the
most responsive to AA stress (12- to 15-fold up-regulation).
Products derived from riboflavin biosynthesis include the
riboflavin derivatives flavin mononucleotide (FMN) and flavin
adenine dinucleotide (FAD), which contribute to fatty acid
oxidation and oxidative stress resistance (Ross and Hansen,
1992; Ashoori and Saedisomeolia, 2014). Despite this, ribF
(SPD_0994), which is responsible for the conversion of riboflavin
to FMN and FADwas not differentially expressed, indicating that
AA-treated pneumococci likely overproduce riboflavin without
full conversion to FMN and FAD cofactors. This corroborates
previous studies on Bacillus subtilis, which have shown that
FMN functions as a repressor of the riboflavin biosynthetic
pathway (Mack et al., 1998). Although relatively little is known
about the function of riboflavin, the vitamin has been shown
to directly bind metal ions (Albert, 1950) and as such may
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serve as a component of the intracellular buffer for metal ions.
Pneumococcal metal ion homeostasis is affected by AA stress,
with a putative ferric iron ABC permease (SPD_1607-10; ∼3.7-
fold), a putative magnesium importer (SPD_1606; 3-fold) and
the manganese ABC permease (psaBCA;∼3-fold; McDevitt et al.,
2011; Counago et al., 2014; Eijkelkamp et al., 2014a, 2015) all
showing significant up-regulation. Although whole cell metal
ion determination did not reveal significant difference in the
concentration of first row transition metal ions (manganese iron,
copper, or zinc; Figure S4), the increased transcription of these
transporters suggest that the intracellular abundance of metal
ions sensed by key regulators, such as PsaR, may be perturbed
by the increased riboflavin levels.
In addition to the perturbation of metal ion homeostatic
regulation, increased transcription of alkyl hydroperoxide
reductase (ahpD; SPD_0373; 5.5-fold) was observed, suggesting
that AA induces oxidative stress (Schönfeld and Wojtczak, 2008;
Desbois and Smith, 2010). However, treatment with AA did not
result in increased susceptibility of S. pneumoniae to H2O2 or the
superoxide-inducing compound, paraquat (Figure S5A,B). As a
consequence, the apparent lack of heightened susceptibility may
be due to the induction of AhpD and other related pathways in
response to AA.
Treatment with AA also resulted in the up-regulation of
multiple alcohol dehydrogenases (ADHs) including SPD_1636
(3.0-fold), SPD_1834 (4.4-fold) and SPD_1865 (4.7-fold). To
examine the basis for this, the cellular ethanol abundance of
untreated and AA-treated cells was assessed, revealing 2-fold
higher ethanol accumulation in AA-treated cells by comparison
with the untreated cells (Figure 5). The up-regulation of the
ADHs and increased ethanol abundance may arise from the
increased use of mixed acid fermentation for energy production
in the presence of AA stress. This is further supported by the
up-regulation of gene clusters associated with carbon-source
utilization, including those for mannose (SPD_0295-7; > 2-fold
up-regulated) and galactose (SPD_1613-16; > 4-fold) (Figure 3
and Table S2).
Genes that were differentially transcribed upon AA treatment,
but not directly linked to fatty acid/membrane biology or
oxidative stress tolerance included a putative bacteriocin
transport system (SPD_0113-5; ∼10-fold down), a putative
hemolysin (SPD_1295, 3.8-fold down) and a cluster encoding
a GntR-type regulator and a putative antimicrobial peptide
ABC transporter (SPD_1524-6; ∼5-fold down) (Figure 3).
Both bacteriocins and hemolysins are known colonization and
virulence factors (Chen et al., 2004; Dawid et al., 2007), hence
their down-regulation upon exposure to AA may restrict the
ability of the pneumococcus to cause disease. SPD_1524 encodes
a YtrA-like regulator of the GntR family of transcriptional
regulators, which are commonly co-transcribed with ABC
transporters (Suvorova et al., 2015), as seen with this particular
cluster. Although the ligands of YtrA-regulators are largely
unknown, fatty acids have previously been shown to be
exported by these types of ABC transporters (Suvorova et al.,
2015). A putative YtrA-binding site identified upstream of
SPD_1524 indicates its auto-regulation (data not shown). Further
genomic analyses revealed highly homologous YtrA-binding
FIGURE 5 | Cellular ethanol abundance. Intracellular ethanol abundance of S.
pneumoniae D39 grown in the presence (white bar) and absence (black bar) of
62.5µM AA supplementation. Ethanol abundance is relative to untreated D39.
The data are the mean of 5 biological replicates (±SEM). Statistical analyses
were performed by Student’s unpaired t-test (***p < 0.0005).
motifs upstream of SPD_0686-8, but this cluster, encoding
various eﬄux systems, was only marginally down-regulated (<2-
fold).
Collectively, the impact of AA stress on the pneumococcal
transcriptome showed that, in addition to dysregulating fatty acid
biosynthesis, there was a broad range of affected genes including
those of the YycFG regulon. Together, the effects mediated by AA
resulted in metabolic by-products of cellular energy production
suggesting that AA stress was also influencing carbon source
utilization by S. pneumoniae.
CONCLUSIONS
Our study is the first to examine the molecular basis of the
clinically relevant LC-PUFA AA and its antimicrobial potential.
Our analyses show that AA abundance increased in blood
plasma upon infection, which may have substantial effects on
bacteremic pathogens such as the pneumococcus. Further,
we revealed a contribution by AA in killing S. pneumoniae
within phagocytic cells, highlighting the potential significance
of AA in host niches. Our subsequent analyses of the effect of
AA on the pneumococcus showed that this exogenous fatty
acid disrupts bacterial membrane homeostasis through two
distinct pathways. First, AA is readily incorporated into bacterial
membranes, which has detrimental effects on membrane
integrity due to the length and number of double bonds in
AA, by comparison with the endogenous membrane fatty acids
of the pneumococcal membrane. Indeed, treatment with AA
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resulted in a significant increase in pneumococcal membrane
fluidity. Intriguingly, the AA-treated cells did not display
increased susceptibility to a range of different exogenous stresses,
e.g., oxidative, metal or antibiotic stress. In fact, AA-treated
cells were significantly more resistant to killing by the human
antimicrobial peptide LL-37. The differences in membrane
fluidity may also affect the correct insertion and stabilization
of membrane proteins for cellular function, however this
requires further investigation. The alternative mechanism of
AA’s antimicrobial action is achieved by compromising the
pneumococcal membrane through dysregulation of the fatty acid
biosynthesis genes.
Interestingly, in many other bacterial pathogens, eﬄux
systems are upregulated in response to fatty acid toxicity (Lee
and Shafer, 1999; Schielke et al., 2010). However, despite the
broad impact of AA on the pneumococcal transcriptome, we
did not identify any apparent resistance mechanisms that may
mitigate the toxicity of AA upon this bacterium, which highlights
the potential of AA as an effective anti-pneumococcal treatment
strategy.
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Figure S1 | The effect of AA treatment upon tolerance to antimicrobial stresses.
Examination of the pneumococcal growth with or without 62.5µM AA and with or
without (A) 4 µg.mL−1 gentamicin, (B) 1 µg.mL−1 chloramphenicol, (C) 250µM
zinc, or (D) 500µM copper. The OD600 was determined every 30min. Data is
representative of at least biological triplicate (± SEM) and where error bars are not
visible this is due to occlusion by the shown symbols.
Figure S2 | Validation of the RNA sequencing data by qRT-PCR. The mRNA
transcription levels of SPD_0378, SPD_0382, SPD_0380, SPD_0309 and
SPD_0772, were determined by qRT-PCR and plotted against the data obtained
by RNA sequencing. Transcription levels were examined in the presence of
62.5µM AA and corrected to untreated cells following internal normalization to
16S. qRT-PCR data are representative of at least biological triplicates. The R2
value is 0.9847, which was calculated using Prism 7 (GraphPad).
Figure S3 | The role of fakB in host fatty acid resistance. Examination of wild-type
and fakB mutant (1fakB) growth with or without 62.5µM AA (A) or DHA (B). The
OD600 was determined every 30min. Data is representative of at least biological
triplicate (±SEM) and where error bars are not visible this is due to occlusion by
the shown symbols.
Figure S4 | Whole cell metal content analysis of untreated and AA-treated
pneumococci. In vitro accumulation of manganese, iron, zinc and copper were
assessed via growth in C+Y with or without supplementation with 62.5µM AA.
Metal content is expressed as µg of metal per g of dry cells, as determined by
ICP-MS. Data are the mean (±SEM) of at least biological triplicates. Statistical
significance was determined using a two-tailed unpaired Student’s t-test, where
“ns” represents not significant.
Figure S5 | The effect of AA treatment upon tolerance to oxidative stress.
Examination of the pneumococcal growth with or without 62.5µM AA and with or
without (A) 250µM H2O2 or (B) 250µM paraquat. The OD600 was determined
every 30min. Data is representative of at least biological triplicate (± SEM) and
where error bars are not visible this is due to occlusion by the shown symbols.
Table S1 | Oligonucleotides used in this study.
Table S2 | Transcriptomic data (>2-fold differential expression).
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